News

Welcome to the news and media section of our website, where we feature corporate news releases and media coverage of interest.

 

mare and foal + product box and vial

U.S. Study Demonstrates Positive Effect of Settle® on Endometrial Cups

Data from a study conducted by Gluck Equine Research Center (UKY) and Rood & Riddle Equine Hospital has demonstrated efficacy of Settle® to treat endometrial cups in mares. No other treatment has been found effective to date.

Feedlot Safety Study with Amplimune® Published in the Australian Veterinary Journal

A paper has been published in the Australian Veterinary Journal, “The innate immune stimulant Amplimune® is safe to administer to young feedlot cattle”, summarizing a research study conducted by CSIRO.

MCWF (Amplimune) Significantly Improves Fertility and Decreases Clinical Mastitis and Metritis in Organic-Certified Dairy Herd

In a newly published study, the incidence rates of both clinical mastitis and metritis before 28 days in milk were lower, and pregnancy rates (3 time points) were higher in Amplimune-treated cows vs. placebo-treated controls.

Amplimune® Now Available in New Zealand

NovaVive's immunotherapy for calf scours - Amplimune® - is now available in the New Zealand market. The product was approved for sale by Agricultural Compounds and Veterinary Medicines (ACVM) last September.

3 calves in a field

MCWF Greatly Improves Pregnancy Success in Heifer Embryo Transfer Recipients

An abstract being presented at the 2021 IETS Virtual Conference summarizes data from a study showing 45% of Amplimune-treated embryo transfer recipient heifers achieved pregnancy at Day 60 vs. 28% of untreated controls.

Holstein calf looking at camera

Amplimune® Receives Regulatory Approval in New Zealand

NovaVive's immunotherapy for calf scours - Amplimune® - has received approval for sale in New Zealand by Agricultural Compounds and Veterinary Medicines (ACVM). NovaVive has appointed Agilis Vet Ltd as its NZ distributor.

Sign up to stay up-to-date with NovaVive news.